My child is growing and now? Exploring the environmental needs of children with congenital Zika syndrome according to their caregivers' perceptions. [PDF]
Health Expect, 2022 Abstract Introduction Promoting social inclusion of children with congenital Zika virus syndrome (CZS) is challenging, mostly, when there is a transport problem, low access to information and a long distance between the house and health services. Participation can be understood as involvement in a life situation and is strongly influenced by physical ...
Coelho MLG +7 more
europepmc +2 more sources
Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. [PDF]
Epilepsia Open, 2021 Abstract Febrile infection‐related epilepsy syndrome (FIRES) is a rare catastrophic epileptic encephalopathy that presents suddenly in otherwise normal children and young adults causing significant neurological disability, chronic epilepsy, and high rates of mortality.
Koh S +20 more
europepmc +2 more sources
The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis. [PDF]
Vet Dermatol, 2022 Background– Cannabidiol (CBD) and cannabidiolic acid (CBDA) are reported to have antinociceptive, immunomodulatory and anti‐inflammatory actions. Objectives – To determine if CBD/CBDA is an effective therapy for canine atopic dermatitis (cAD). Conclusions and clinical relevance – Cannabidiol/CBDA as an adjunct therapy decreased pruritus, and not skin ...
Loewinger M +4 more
europepmc +2 more sources
Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome. [PDF]
J Cell Mol Med, 2020 Abstract Considering lack of target‐specific antiviral treatment and vaccination for COVID‐19, it is absolutely exigent to have an effective therapeutic modality to reduce hospitalization and mortality rate as well as to improve COVID‐19‐infected patient outcomes. In a follow‐up study to our recent findings indicating the potential of Cannabidiol (CBD)
Salles ÉL +9 more
europepmc +2 more sources
Desafios para promoção do acesso ao Canabidiol na Rede Pública de Saúde do Distrito Federal
Jornal de Assistência Farmacêutica e Farmacoeconomia, 2023 Introdução: O canabidiol é uma substância encontrada na planta Cannabis, usada em diversas condições clínicas como epilepsia, dor crônica, depressão e ansiedade.
Silas Dino de Sousa +3 more
doaj +1 more source
O uso de canabinoides de Cannabis sativa L. no tratamento da epilepsia: uma revisão integrativa [PDF]
Infarma: Pharmaceutical Sciences, 2022 O uso da Cannabis sativa para fins medicinais é um assunto bastante polêmico no Brasil, por isso é necessário se aprofundar no tema para elucidar as principais dúvidas e possíveis benefícios.
Lucas Alonso Lopes +3 more
doaj +1 more source
Effects of Vitamin C on the Prevention of Ischemia-Reperfusion Brain Injury: Experimental Study in Rats. [PDF]
Int J Vasc Med, 2019 Background. Reperfusion syndrome after carotid endarterectomy is a complication associated with cerebrovascular self‐regulation in a chronically hypoperfused cerebral hemisphere, leading to severe neurological damage. Vitamin C is an important antioxidant in brain metabolism that has shown some neuroprotective actions. Objective.
de Sales KPF +6 more
europepmc +2 more sources
Jornal de Assistência Farmacêutica e Farmacoeconomia, 2023 Introdução: A efetividade do canabidiol tem sido evidenciada na redução de crises convulsivas em pacientes refratários aos tratamentos convencionais. Com base nestas evidências, a Lei Distrital nº 5.625, de 14 de março de 2016, instituiu o Programa de ...
Ronaldo Portela +5 more
doaj +1 more source
Cannabinoids help to unravel etiological aspects in common and bring hope for the treatment of autism and epilepsy [PDF]
, 2014 Desde 1843 que as propriedades anticonvulsivantes da Cannabis são conhecidas pela ciência ocidental. Em 1980, ensaios clínicos demonstraram que canabidiol possui atividade antiepilética em pacientes de epilepsia refratária, sendo sonolência o único ...
Jianguang Wen (3807526) +10 more
core +3 more sources
Uso terapêutico de produtos à base de canabidiol no Brasil: estudo descritivo, 2014–2017
Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2019 Introdução: Pouco se conhece sobre as características e as condições clínicas dos pacientes em uso terapêutico de produtos à base de canabidiol, apesar de um número crescente de países ter autorizado o uso desses produtos.
Daniel Marques Mota +5 more
doaj +7 more sources